Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Taxotere in High Risk Prostate Cancer
NCT00186420Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jul 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by Stanford University. Primary endpoint: Time to Progression by PSA. Started Jul 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00186420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186420.